The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice

The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice

Maintaining target glycosylated hemoglobin (HbA(1c)) (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes technology & therapeutics 2008-04, Vol.10 (2), p.121-127
Hauptverfasser: Schreiber, Stephan A, Ferlinz, Klaus, Haak, Thomas
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Aged, 80 and over
Blood Glucose - metabolism
Body Mass Index
Body Weight - drug effects
Body Weight - physiology
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - physiopathology
Diagnosis
Dosage and administration
Dose-Response Relationship, Drug
Drug therapy
Drug Therapy, Combination
Female
Follow-Up Studies
Glycated Hemoglobin A - metabolism
Glycosylated hemoglobin
Humans
Hypoglycemic Agents - therapeutic use
Insulin - analogs & derivatives
Insulin - therapeutic use
Insulin Glargine
Insulin, Long-Acting
Longitudinal Studies
Male
Measurement
Middle Aged
Treatment Outcome
Type 2 diabetes
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Maintaining target glycosylated hemoglobin (HbA(1c)) (
ISSN:1520-9156
1557-8593
DOI:10.1089/dia.2007.0265